Morgan Stanley
-
-
-
-
-
-
-
Bristol-Myers Squibb: Morgan Stanley highlights catalyst driven idea
-
-
-
-
-
-
-
Midday movers: Microsoft, Boeing, Bristol-Myers Squibb, and more
-
-
-
-
-
-
-
Bristol Myers Squibb Enters Into $4 Billion Aggregate Accelerated Share Repurchase Agreements
-
-
-
-
-
-
-
UPDATE: Morgan Stanley Assumes Bristol-Myers Squibb Co. (BMY) at Underweight
-
-
-
-
-
-
-
Berkshire Hathaway Inc. (BRK-B) is a Net Seller in 2Q, Adds One, Liquidates Two Positions
-
-
-
-
-
-
-
CVR Being Worthless is Positive for Bristol-Myers Squibb Co. (BMY) - Morgan Stanley
-
-
-
-
-
-
-
Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company
-
224,988 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

